即将上市(暗盘交易时段:今日16:15-18:30)
| 公司名称▼
/
代号▼ | 行业 | 招股价 | 每手股数 | 入场费 | 招股截止日 | 暗盘日期▼ | 上市日期▲ |
| 派格生物医药─B 02565.HK | 生物科技- 制药 | 15.6 | 500 | N/A | 2025/05/22 |
2025/05/26 | 2025/05/27 |
| 吉宏股份 02603.HK | 纸制品 | 7.48-10.68 | 500 | 5,394 | 2025/05/22 |
2025/05/26 | 2025/05/27 |
公司名称/代号 | 现价2 | 今日升跌▼ | 十天升跌▼ | 市值▼ | 市盈率 (倍)▼ | 市帐率 (倍)▼ | 派息比率 (%)▼ | 股东权益 回报率(%)▼ | 经营 利润率(%)▼ | 总债项/ 股东权益(%)▼ | 选择比较 |
派格生物医药 (杭州 )股份 02565.HK | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -14,693.00% | N/A | 3,629.00% | |
信达生物 01801.HK | 55.900 | +1.085% | +6.88% | 922.09亿 | N/A | 6.56 | N/A | -72.00% | 32.00% | 2,158.00% | |
康方生物 09926.HK | 87.900 | +6.675% | +5.02% | 788.98亿 | N/A | 10.89 | N/A | -755.00% | -1,715.00% | 5,800.00% | |
中国生物制药 01177.HK | 4.190 | +0.239% | +9.40% | 786.45亿 | 20.59 | 2.32 | 34.398% | 1,095.00% | 2,562.00% | 3,038.00% | |
科伦博泰生物-B 06990.HK | 336.800 | +0.238% | +6.92% | 528.28亿 | N/A | 21.75 | N/A | -806.00% | -718.00% | 383.00% | |
三生制药 01530.HK | 20.850 | +8.707% | +80.36% | 500.10亿 | 22.73 | 3.04 | 27.254% | 1,354.00% | 2,811.00% | 2,303.00% | |
药明合联 02268.HK | 38.350 | -0.648% | +9.26% | 461.23亿 | 40.40 | 6.52 | N/A | 1,611.00% | 3,018.00% | 748.00% | |
诺诚健华 09969.HK | 10.980 | +3.585% | +14.97% | 193.34亿 | N/A | 2.71 | N/A | -655.00% | -4,097.00% | 1,891.00% | |
和黄医药 00013.HK | 21.300 | +0.472% | -6.17% | 185.65亿 | 62.21 | 3.15 | N/A | 496.00% | 28.00% | 1,182.00% | |
映恩生物-B 09606.HK | 195.000 | -2.500% | -2.99% | 171.67亿 | N/A | N/A | N/A | -5,195.00% | -5,225.00% | N/A | |
康宁杰瑞制药-B 09966.HK | 8.980 | +18.003% | +17.69% | 86.39亿 | 48.86 | 4.43 | N/A | 908.00% | 2,754.00% | 1,015.00% | |
同源康医药-B 02410.HK | 22.450 | +2.278% | -29.62% | 82.22亿 | N/A | 16.69 | N/A | -8,249.00% | -35,057,103.00% | 3,770.00% | |
绿叶制药 02186.HK | 2.090 | +2.956% | +3.47% | 78.62亿 | 15.67 | 0.52 | N/A | 333.00% | 2,313.00% | 7,292.00% | |
复宏汉霖 02696.HK | 43.500 | +7.275% | +18.85% | 71.09亿 | 27.09 | 7.38 | N/A | 2,723.00% | 1,692.00% | 12,106.00% | |
博安生物 06955.HK | 11.000 | +8.055% | +17.77% | 58.95亿 | 75.76 | 3.37 | N/A | 445.00% | 1,457.00% | 4,170.00% | |
维升药业-B 02561.HK | 45.750 | +3.859% | -0.33% | 52.12亿 | N/A | N/A | N/A | -7,553.00% | N/A | 98.00% | |
绿竹生物-B 02480.HK | 21.400 | +0.234% | -2.73% | 42.64亿 | N/A | 4.74 | N/A | -1,971.00% | N/A | 791.00% | |
君实生物 01877.HK | 16.940 | +8.036% | +13.39% | 37.15亿 | N/A | 2.67 | N/A | -2,181.00% | -6,532.00% | 4,986.00% | |
宜明昂科-B 01541.HK | 8.200 | +9.188% | +35.76% | 32.49亿 | N/A | 4.63 | N/A | -4,652.00% | -42,231.00% | 2,009.00% | |
亿胜生物科技 01061.HK | 4.700 | +1.075% | +8.05% | 26.65亿 | 8.68 | 1.26 | 22.165% | 1,447.00% | 2,303.00% | 881.00% | |
德琪医药-B 06996.HK | 3.870 | +4.032% | +35.31% | 26.29亿 | N/A | 2.91 | N/A | -3,752.00% | -34,650.00% | 2,932.00% | |
|